Breast Cancer Trial, Recruiting NCT05300464 Sponsor: Umbria Bioengineering Technologies Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05300464
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have signed a consent form agreeing to take part in the study
  • Women aged 18 or older
  • People who have had a mammogram in the last month, with results available (these results may also include ultrasound or MRI scans, and tissue sample results, if the doctor in charge considers them relevant and they are available)
  • People who are willing to follow the study procedures and recommendations throughout the trial

Who may not be able to join:

  • People who are considered part of a vulnerable group (confirm with trial site for details on what this includes)
  • People who have an electronic device implanted in their body (such as a pacemaker)
  • People who have had a breast tissue biopsy less than one week before the MammoWave scan
  • People who have nipple piercings, unless those piercings are removed before the examination
  • People who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0039 34900564302

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Umbria Bioengineering Technologies
Registry
ClinicalTrials.gov
Start date
7 January 2023
Est. completion
30 September 2026

Where this trial is recruiting

🇮🇹 Italy 🇪🇸 Spain

Primary endpoints

MammoWave sensitivity (number of 'true positive' results)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov